| III-082 Chetan Rathi Translational PK-Tumor Growth Inhibition (TGI) modeling of type 1 PRMT and PRMT5 inhibitor combination to predict clinical response Thursday 09:50-11:20 |
| III-082 Chetan Rathi Translational PK-Tumor Growth Inhibition (TGI) modeling of type 1 PRMT and PRMT5 inhibitor combination to predict clinical response Thursday 09:50-11:20 |